Draig Therapeutics Launches with $140 Million (107 Million) Total Investment to Advance its Portfolio of Next-Generation Therapies for Major Neuropsychiatric Disorders
Clinical-stage company led by world-class team targeting core neurotransmission pathways underlying neuropsychiatric…
Unmatched Grit, Major Glory: J.J. Spaun Conquers Oakmont to Win First Major Championship
HUNTINGTON BEACH, Calif., June 15, 2025 – With unwavering resilience and poise,…
Access Medical Labs, a Subsidiary of Empresas Aries, Completes Historic Lab Expansion with Roche Diagnostics Systems
JUPITER, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- In a milestone rarely…
Metamorphoses | 2025 CAA Graduation Season
HANGZHOU, China, June 10, 2025 /PRNewswire/ -- As 2025 approaches its most…
Rakovina Therapeutics Announces the Closing of Oversubscribed Private Placement of $4.9 Million
VANCOUVER, British Columbia, June 06, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc.…
Sold Out Twice in 6 Months: Pilgrim’s Viral Lipstick Launch Breaks the Internet
MUMBAI, India, June 5, 2025 /PRNewswire/ -- Pilgrim, one of India's fastest-growing…
SafeTree Launches India’s First Maternity Insurance Tailored for IVF Couples with Just 7-Month Waiting Period
NEW DELHI, June 4, 2025 /PRNewswire/ -- In a groundbreaking step towards…
Kia America Posts Eighth Consecutive Month of YearOverYear Sales Growth
79,007 units sold in May, a 5-percent increase compared to previous yearBest-ever…
Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment of Metastatic Pancreatic Cancer
Phase 2 (Actuate-1801 Part 3B) trial meets primary endpoint and demonstrates a…
Tesco’s Clubcard Challenges, Powered by Eagle Eye, Wins “Best Global Loyalty Launch or Initiative” at the 2025 International Loyalty Awards
LONDON, May 28, 2025 /PRNewswire/ -- Tesco's Clubcard Challenges, powered by Eagle Eye's…